{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:40Z","timestamp":1792979920582,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is the most common metabolic disorder in the reproductive age group, the pathogenesis of which is constantly evolving with the discovery of novel molecules and the lookout for potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of the present study was to estimate the circulating levels of serum adiponectin in patients with PCOS compared to controls and to find its correlation with markers of cardiovascular risk, with special emphasis on circulating levels of oxidised low-density lipoprotein (oxLDL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>In this cross-sectional observational study recently diagnosed, PCOS subjects were compared with age- and body mass index (BMI)-matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>All the included subjects underwent detailed clinical, biochemical and hormonal evaluation, including lipid profile, 75 g oral glucose tolerance test, fasting serum insulin, fasting serum adiponectin, oxLDL, total testosterone and anti-Mullerian hormone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Appropriate statistical methods were performed using SPSS (version 21) and Microsoft Excel (2019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 56 PCOS cases and 32 controls were included in the study. Mean values of serum adiponectin (\u03bcg\/mL) in our study were found to be significantly lower in PCOS cases (11.53 \u00b1 4.74) versus controls (14.73 \u00b1 5.61) irrespective of BMI. Mean values of serum oxLDL (\u03bcg\/dL) were found to be higher in PCOS cases (157.96 \u00b1 53.89) versus controls (117.52 \u00b1 45.44), with a significant negative correlation between adiponectin and oxLDL in cases. No difference in levels of adiponectin was found between the different PCOS phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hypoadiponectinaemia was found to be associated with PCOS irrespective of obesity in PCOS subjects. Serum oxLDL can complement adiponectin as early predictor of CV risk in PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_95_23","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T19:00:33Z","timestamp":1703876433000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A Study of Serum Adiponectin Levels in Patients with Polycystic Ovarian Syndrome and its Correlation with Various Cardiometabolic Risk Markers"],"prefix":"10.4103","volume":"16","author":[{"given":"G. Surendra","family":"Prasad","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Medicover Hospital, Hyderabad, Telangana, India"},{"name":"Department of Endocrinology, Gauhati Medical College and Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Kaimal","family":"Saikia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Gauhati Medical College and Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Krishna","family":"Bhuyan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Gauhati Medical College and Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhamoni","family":"Baro","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Gauhati Medical College and Hospital, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"R1-20240905","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"R2-20240905","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr Rev"},{"key":"R4-20240905","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.ATV.21.5.844","article-title":"Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease","volume":"21","author":"Holvoet","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-20240905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R6-20240905","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"R7-20240905","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/humrep\/den211","article-title":"Obesity, body composition and metabolic disturbances in polycystic ovary syndrome","volume":"23","author":"Svendsen","year":"2008","journal-title":"Hum Reprod"},{"key":"R8-20240905","doi-asserted-by":"crossref","first-page":"37487","DOI":"10.1074\/jbc.M206083200","article-title":"Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis","volume":"277","author":"Matsuda","year":"2002","journal-title":"J Biol Chem"},{"key":"R9-20240905","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18231\/j.ijogr.2019.065","article-title":"Study of serum adiponectin levels in women with polycystic ovary syndrome","volume":"6","author":"Gowthami","year":"2019","journal-title":"Indian J Obstet Gynecol Res"},{"key":"R10-20240905","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1757-2215-7-18","article-title":"Association between circulating adiponectin levels and polycystic ovarian syndrome","volume":"7","author":"Mirza","year":"2014","journal-title":"J Ovarian Res"},{"key":"R11-20240905","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi","year":"2005","journal-title":"Fertil Steril"},{"key":"R12-20240905","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1210\/jc.2007-2759","article-title":"Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: Associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20240905","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.1.01868","article-title":"Evidence for altered adipocyte function in polycystic ovary syndrome","volume":"152","author":"Carmina","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R14-20240905","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.fertnstert.2007.04.046","article-title":"Circulating and cellular adiponectin in polycystic ovary syndrome: Relationship to glucose tolerance and insulin action","volume":"89","author":"Aroda","year":"2008","journal-title":"Fertil Steril"},{"key":"R15-20240905","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3126\/nmcj.v23i2.38570","article-title":"Association between leptin and adiponectin in women with polycystic ovary syndrome in North Indian population","volume":"23","author":"Talat","year":"2021","journal-title":"Nepal Med Coll J"},{"key":"R16-20240905","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/09513590.2014.984676","article-title":"Adiponectin and leptin in overweight\/obese and lean women with polycystic ovary syndrome","volume":"31","author":"Chen","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"R17-20240905","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/2230-8210.129116","article-title":"Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome","volume":"18","author":"Ramanand","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"R18-20240905","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","article-title":"Serum adiponectin levels in women with polycystic ovary syndrome","volume":"18","author":"Panidis","year":"2003","journal-title":"Hum Reprod"},{"key":"R19-20240905","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","article-title":"Adiponectin levels in women with polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20240905","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4236\/ojemd.2012.24019","article-title":"Serum adiponectin levels in different phenotypes of polycystic ovary syndrome","volume":"2","author":"Otta","year":"2012","journal-title":"Open J Endocr Metab Dis"},{"key":"R21-20240905","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","article-title":"Adiponectin and resistin in PCOS: A clinical, biochemical and molecular genetic study","volume":"21","author":"Escobar-Morreale","year":"2006","journal-title":"Hum Reprod"},{"key":"R22-20240905","first-page":"27","article-title":"Relationship between Serum levels of anti-Mullerian hormone, adiponectin and oxidative stress markers in patients with polycystic ovary syndrome","volume":"14","author":"Kohzadi","year":"2020","journal-title":"Int J Fertil Steril"},{"key":"R23-20240905","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","article-title":"Differences of the association of anti-M\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome","volume":"59","author":"Woo","year":"2012","journal-title":"Endocr J"},{"key":"R24-20240905","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/HYPERTENSIONAHA.107.099424","article-title":"Adiponectin, cardiovascular function, and hypertension","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"key":"R25-20240905","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","article-title":"The sympathetic nervous system and the metabolic syndrome","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R26-20240905","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4082\/kjfm.2011.32.4.243","article-title":"Adiponectin in women with polycystic ovary syndrome","volume":"32","author":"Shin","year":"2011","journal-title":"Korean J Fam Med"},{"key":"R27-20240905","first-page":"64","article-title":"Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome","volume":"100","author":"Gulcelik","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"R28-20240905","doi-asserted-by":"crossref","first-page":"24N","DOI":"10.1016\/S0002-9149(01)02149-X","article-title":"Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism","volume":"88","author":"Fruchart","year":"2001","journal-title":"Am J Cardiol"},{"key":"R29-20240905","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12291-011-0119-1","article-title":"Correlation of adiponectin and leptin with insulin resistance: A pilot study in healthy North Indian population","volume":"26","author":"Yadav","year":"2011","journal-title":"Indian J Clin Biochem"},{"key":"R30-20240905","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/eje.1.02187","article-title":"Oxidised low-density lipoprotein concentration \u2013Early marker of an altered lipid metabolism in young women with PCOS","volume":"155","author":"Macut","year":"2006","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_95_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:57:37Z","timestamp":1787763457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_95_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_95_23","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}